通便方治疗肛肠病术后津亏肠燥型便秘临床疗效观察

发布时间：2018-03-21 09:01

本文选题：通便方　切入点：肛肠病术后津亏肠燥型便秘　出处：《河南中医药大学》2016年硕士论文　论文类型：学位论文

【摘要】：目的:本课题系统的观察了导师自拟通便方治疗肛肠病术后津亏肠燥型便秘的有效性及安全性,通过与滋阴润肠口服液做对比,观察通便方治疗肛肠病术后津亏肠燥型便秘的治疗效果,并对其安全性进行评估、分析、评价,最终总结这个经验方在治疗肛肠病术后津亏肠燥型便秘患者的治疗效果及安全性,为在临床上治疗肛肠病术后津亏肠燥型便秘,提供一个合理、科学、安全的方法。方法:所有资料均来源于河南中医药大学第二附属医院肛肠病区,2015年4月—2016年2月的肛肠病术后津亏肠燥型便秘患者。将80例符合纳入标准的肛肠疾病手术后属于津亏肠燥型的便秘住院患者,按照每个患者入院时所生成的住院号,采用随机数字表法随机分为治疗组和对照组,每组40例。在常规治疗的基础上,治疗组给予导师自拟方通便方,每日1剂,每剂煎400ml,早晚温服。对照组给予滋阴润肠口服液,1支/次,日3次,口服。7天为一个疗程,治疗两个疗程。观察治疗两个疗程后通便方对肛肠病术后津亏肠燥型便秘患者在排便间隔时间、排便时间、排便次数、排便困难程度、排便出血及排便时的疼痛程度在临床症状积分上的变化。结果:通过spss18.0统计软件统计、处理、分析之后得出结论:(1)治疗组与对照组的患者在经过分别治疗后,将两者总的有效率进行对比,有显著性的不同,即(P值0.05);(2)治疗组与对照组患者在进行分别的治疗后,在临床症状上,积分较治疗前降低,与治疗前相比,都有很大的不同,即(P值0.05)。治疗组排便间隔时间、排便时间、排便次数、排便困难程度、排便出血及排便时的疼痛程度情况比较,都有显著性的差异,即(P值0.05)。结论:通便方能有效改善肛肠病术后津亏肠燥型便秘患者排便间隔时间、排便时间、排便次数、排便困难程度、排便出血及排便疼痛程度,减轻了患者的痛苦,提高了患者的生活质量,且无明显不良反应及毒副作用,值得临床推广应用。
[Abstract]:Objective: to observe the efficacy and safety of tutors' self-designed Tongbian recipe in the treatment of post-anal bowel disease constipation, and to compare it with Ziyin Runchang oral liquid. To observe the therapeutic effect of Tongbian recipe in the treatment of postoperative constipation caused by ataxia and intestinal dryness, and to evaluate its safety, to evaluate, analyze and evaluate the safety of the constipation. Finally, we summarize the effect and safety of this experience prescription in the treatment of patients with post-anal bowel disease, which provides a reasonable and scientific method for the treatment of post-operative constipation. Methods: all data were obtained from the anorectal disease area of the second affiliated hospital of Henan university of traditional Chinese medicine. From April 2015 to February 2016, 80 patients with anal-intestinal dryness constipation after operation of anorectal disease were included. Inpatients with constipation that belong to the type of intestinal dryness after the operation of the disease, According to the hospital number generated by each patient on admission, the treatment group was randomly divided into treatment group (n = 40) and control group (n = 40). The control group was given 1 dose of Ziyin Runchang oral liquid, 3 times a day, and 7 days as a course of treatment. Two courses of treatment. Observe the defecation interval, defecation time, defecation frequency, defecation difficulty degree of the patients with constipation due to defecation after two courses of treatment for anal and intestinal diseases, the defecation interval, the defecation time, the defecation frequency, the defecation difficulty degree, Changes in clinical symptom score of stool bleeding and pain during defecation. Results: spss18.0 statistical software was used to calculate, process, and analyze the clinical symptoms of the patients in the treatment group and the control group, and the results showed that the patients in the treatment group and the control group were treated separately. Comparing the total effective rate of the two groups, there was significant difference, that is, the P value of the treatment group and the control group were 0. 05 and 0. 05% respectively. After the patients in the treatment group and the control group were treated separately, their clinical symptoms were lower than those before the treatment, and there were great differences between the treatment group and the control group before the treatment. There were significant differences in defecation interval, defecation time, defecation frequency, defecation difficulty, stool bleeding and pain in the treatment group. Conclusion: the prescription can effectively improve the defecation interval, defecation time, defecation times, defecation difficulty, defecation bleeding and defecation pain in the patients with constipation due to the deficiency of intestine after operation. The quality of life of the patients was improved, and there were no obvious adverse reactions and side effects, so it is worth popularizing and applying in clinic.
【学位授予单位】：河南中医药大学
【学位级别】：硕士
【学位授予年份】：2016
【分类号】：R266;R256.35

【相似文献】